Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,306,569
+$1,417,778 QoQ
Shares Held
16,957
+43.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#1,725
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Peak Asset Management, LLC holds $10,550,757 across 7 Drug Manufacturers - General names. JNJ ranks #1 (40.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
16,957 | $4,306,569 | |
| 2 | MRK |
Merck & Co., Inc.
|
21,535 | $2,767,247 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
32,175 | $1,853,923 | |
| 4 | PFE |
Pfizer Inc
|
29,704 | $715,272 | |
| 5 | NVO |
Novo Nordisk A S
|
7,200 | $345,168 | |
| 6 | NVS |
Novartis AG
|
2,000 | $313,440 | |
| 7 | AMGN |
Amgen Inc
|
688 | $249,138 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,306,569 | 16,957 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,888,791 | 11,818 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,482,986 | 11,998 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,224,669 | 11,998 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,832,694 | 11,998 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,967,194 | 11,862 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $1,741,369 | 12,041 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,964,005 | 12,119 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,833,431 | 12,544 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,025,306 | 12,803 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,025,864 | 12,925 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,013,068 | 12,925 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,278,217 | 13,764 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,137,295 | 13,789 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,228,969 | 12,618 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $2,071,894 | 12,683 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,204,851 | 12,421 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,330,397 | 13,149 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,279,336 | 13,324 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,109,513 | 13,062 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,151,833 | 13,062 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $2,174,186 | 13,229 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,163,817 | 13,749 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,020,748 | 13,573 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,793,173 | 12,751 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,604,113 | 12,233 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||